Zafgen Inc News - ZFGN

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A ...

Amended Statement of Ownership (sc 13g/a)

SCHEDULE 13G Amendment No. 6 ZAFGEN INC COMMON STOCK Cusip #98885E103 Check the appropriate box to designate the rule...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Statement of Ownership (sc 13g)

us98885e1038_020719.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Zafgen Announces Positive Results for Second Cohort of Phase 2 Clinical Trial of ZGN-1061

Data for the 1.8 mg dose demonstrated meaningfully greater efficacy than the 0.9 mg dose Cohort 2 data...

CURRENT SHAREHOLDERS: Zamansky LLC Investigates Zafgen (ZFGN) for Potential Breaches of Fiduciary Duties

Zamansky LLC announces that it is investigating Zafgen, Inc. (NASDAQ:ZFGN) (“Zafgen” or the “Company”) for potential breaches of fiduciary...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Zafgen Provides Update on Investigational New Drug Application for ZGN-1061

BOSTON, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical...

Zafgen to Present at the 30th Annual Piper Jaffray Healthcare Conference

BOSTON, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-219834...

Securities Registration Statement (simplified Form) (s-3)

Table of Contents As filed with the Securities and Exchange Commission on November 9...

Securities Registration: Employee Benefit Plan (s-8)

As filed with the Securities and Exchange Commission on November 9, 2018 Registration No. 333- &nb...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Zafgen Inc (ZFGN)

Empower your portfolio: Real-time discussions and actionable trading ideas.

ZFGN News

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

Zafgen Announces Positive Results for Second Cohort of Phase 2 Clinical Trial of ZGN-1061

CURRENT SHAREHOLDERS: Zamansky LLC Investigates Zafgen (ZFGN) for Potential Breaches of Fiduciary Duties

Current Report Filing (8-k)

Zafgen Provides Update on Investigational New Drug Application for ZGN-1061

Zafgen to Present at the 30th Annual Piper Jaffray Healthcare Conference

Notice of Effectiveness (effect)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Securities Registration Statement (simplified Form) (s-3)

Securities Registration: Employee Benefit Plan (s-8)

ZFGN Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Zafgen Inc (ZFGN) News

Zafgen Inc (ZFGN)

Empower your portfolio: Real-time discussions and actionable trading ideas.

ZFGN News

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Amended Statement of Ownership (sc 13g/a)

Statement of Ownership (sc 13g)

Current Report Filing (8-k)

Zafgen Announces Positive Results for Second Cohort of Phase 2 Clinical Trial of ZGN-1061

CURRENT SHAREHOLDERS: Zamansky LLC Investigates Zafgen (ZFGN) for Potential Breaches of Fiduciary Duties

Current Report Filing (8-k)

Zafgen Provides Update on Investigational New Drug Application for ZGN-1061

Zafgen to Present at the 30th Annual Piper Jaffray Healthcare Conference

Notice of Effectiveness (effect)

Current Report Filing (8-k)

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

Securities Registration Statement (simplified Form) (s-3)

Securities Registration: Employee Benefit Plan (s-8)

ZFGN Discussion

Your Recent History